Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1987 Nov;63(745):955–957. doi: 10.1136/pgmj.63.745.955

Clostridium difficile, sulphasalazine, and ulcerative colitis.

D A Burke 1, A T Axon 1
PMCID: PMC2428693  PMID: 2897683

Abstract

Clostridium difficile has been implicated in the relapse of ulcerative colitis. Controversy exists over this role and its relationship to sulphasalazine exposure. Sixty two of 77 patients with a documented relapse of ulcerative colitis were investigated for the presence of Clostridium difficile, or its toxin, prior to hospitalization. There was a low incidence of detection which was related to antibiotic exposure (2/62). Sampling during the treatment period showed that the occurrence of Clostridium difficile in the stool was related to antibiotic treatment (2/66). Fifty six percent of patients were taking sulphasalazine, none of whom became culture or toxin positive. This study demonstrates that Clostridium difficile is not related to relapse of ulcerative colitis and is not secondarily acquired during relapse unless the patient is exposed to antibiotics. Sulphasalazine does not predispose to acquisition of Clostridium difficile. There is no role for routine screening or treatment of Clostridium difficile in ulcerative colitis.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein L. H., Frank M. S., Brandt L. J., Boley S. J. Healing of perineal Crohn's disease with metronidazole. Gastroenterology. 1980 Aug;79(2):357–365. [PubMed] [Google Scholar]
  2. Bolton R. P., Sherriff R. J., Read A. E. Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease? Lancet. 1980 Feb 23;1(8165):383–384. doi: 10.1016/s0140-6736(80)90940-x. [DOI] [PubMed] [Google Scholar]
  3. Dickinson R. J., O'Connor H. J., Pinder I., Hamilton I., Johnston D., Axon A. T. Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut. 1985 Dec;26(12):1380–1384. doi: 10.1136/gut.26.12.1380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Greenfield C., Aguilar Ramirez J. R., Pounder R. E., Williams T., Danvers M., Marper S. R., Noone P. Clostridium difficile and inflammatory bowel disease. Gut. 1983 Aug;24(8):713–717. doi: 10.1136/gut.24.8.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Greenfield C., Burroughs A., Szawathowski M., Bass N., Noone P., Pounder R. Is pseudomembranous colitis infectious? Lancet. 1981 Feb 14;1(8216):371–372. doi: 10.1016/s0140-6736(81)91683-4. [DOI] [PubMed] [Google Scholar]
  6. Grove D. I., Mahmound A. A., Warren K. S. Suppression of cell-mediated immunity by metronidazole. Int Arch Allergy Appl Immunol. 1977;54(5):422–427. doi: 10.1159/000231857. [DOI] [PubMed] [Google Scholar]
  7. Keighley M. R., Youngs D., Johnson M., Allan R. N., Burdon D. W. Clostridium difficile toxin in acute diarrhoea complicating inflammatory bowel disease. Gut. 1982 May;23(5):410–414. doi: 10.1136/gut.23.5.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LaMont J. T., Trnka Y. M. Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease. Lancet. 1980 Feb 23;1(8165):381–383. doi: 10.1016/s0140-6736(80)90939-3. [DOI] [PubMed] [Google Scholar]
  9. Meyers S., Mayer L., Bottone E., Desmond E., Janowitz H. D. Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology. 1981 Apr;80(4):697–670. [PubMed] [Google Scholar]
  10. Rolny P., Järnerot G., Möllby R. Occurrence of Clostridium difficile toxin in inflammatory bowel disease. Scand J Gastroenterol. 1983 Jan;18(1):61–64. doi: 10.3109/00365528309181560. [DOI] [PubMed] [Google Scholar]
  11. Sandberg-Gertzen H., Kjellander J., Sundberg-Gillå B., Järnerot G. In vitro effects of sulphasalazine, azodisal sodium, and their metabolites on Clostridium difficile and some other faecal bacteria. Scand J Gastroenterol. 1985 Jun;20(5):607–612. doi: 10.3109/00365528509089704. [DOI] [PubMed] [Google Scholar]
  12. TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Trnka Y. M., LaMont J. T. Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. Gastroenterology. 1981 Apr;80(4):693–696. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES